Ruxotop 1,5% Topical cream 60 g
Marcyrl Pharmaceutical Industries
Marcyrl Pharmaceutical Industries
Overview
Ruxotop 1.5% Cream is a topical formulation of ruxolitinib, a Janus kinase (JAK) inhibitor used in dermatology to help calm inflammation and immune-related skin reactions.
Key Benefits
- Formulated for use in atopic dermatitis (eczema)
- Used in the management of vitiligo (depigmentation disorders)
- May be prescribed for other inflammatory dermatoses as directed by a physician
How to Use
Apply a thin layer to the affected skin areas twice daily, or as prescribed by your physician. For external use only. Duration of treatment depends on clinical response and your doctor's guidance. Use as directed by your pharmacist.
Active Ingredients
Ruxolitinib 15 mg/g (1.5%).
Precautions
Use only under medical supervision. Not for ophthalmic, oral, or intravaginal use. Avoid application to broken or infected skin unless directed by a physician. Do not use if hypersensitive to ruxolitinib or any excipient. Possible local skin reactions may occur; inform your pharmacist if irritation develops.
Storage
Store in a cool, dry place away from direct sunlight and out of the reach of children.